Crédit Industriel et Commercial’s Revance Therapeutics, Inc. RVNC Stock Holding History

Crédit Industriel et Commercial’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-90,085	Closed	-$274K	–	444
2024 Q4	$274K	Buy	+90,085	New	+$392K	0.04%	246

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Crédit Industriel et Commercial's RVNC Position: Q1 2025 in Review

Crédit Industriel et Commercial sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 90,085 shares — an estimated $274K sold.

Crédit Industriel et Commercial first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $274K in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

Crédit Industriel et Commercial reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 90,085 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $274K.
Crédit Industriel et Commercial first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
Crédit Industriel et Commercial's Revance Therapeutics, Inc. position peaked at $274K in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2025, filed 15 May 2025.